Health

• Corporates invested 43% less capital in startup funding rounds in 2023 compared with the previous year. • The number of active corporate investors fell by 17%, as many opted to wait out poor market conditions. • The number of corporates taking LP positions in VC funds fell to its lowest level in a decade.

Backed by JPMorgan Chase, Honeywell, Amgen, Mitsui & Co, Quantinuum is working both on quantum hardware and software — and is now one of the biggest players in the field.

Koch Disruptive Technologies has promoted Israel-based director Jon Galitzer to a US managing director role.

Biotech venture capital is shrinking from boomtime highs, but Sakae Asanuma, CEO of Taiho Ventures, says now is a good time to find new novel treatments to back.

The Brazilian education and health provider is expanding its startup investments following a strategic update last year.

GUV is launching a weekly spinout tracker to surface the most exciting new and emerging companies based on university research.

Six tips on how to create a high-performing platform team that can create strategic value from startup investments.

GV backs another spinout by MIT’s serial entrepreneur Feng Zhang as epigenetics becomes an emerging area of healthcare.

Pharmaceutical startups have had a strong start to 2024, showing off areas like psychedelic mental health treatments, radiotherapeutic cancer drugs and medicine for underserved populations.

Japanese pharma firm Taiho has added $100m to its US-based CVC subsidiary, which has a team of five people.

Bauke Anninga was a principal at M Ventures for two years.